skip to main content

Chemistry, part 1

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > ganglioside > sialopentaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > ganglioside > sialopentaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > ceramide > ganglioside > sialopentaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > ganglioside > sialopentaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carboxamide > ceramide > ganglioside > sialopentaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > ganglioside > sialopentaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer

Preferred term

beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C64H109N4O36R

mass

  • 1510.558

monoisotopicmass

  • 1509.68215

smiles

  • [C@@]1(O[C@]([C@@H]([C@H](C1)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])(C(O)=O)O[C@H]2[C@H]([C@H](O[C@@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](O)[C@H]([C@H](O[C@@H]5[C@H](O[C@@H](OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)NC(=O)*)[C@@H]([C@H]5O)O)CO)O[C@@H]4CO)O)O[C@H](CO)[C@@H]3O)NC(C)=O)[C@@H]2O)CO)O[C@H]6[C@@H]([C@H]([C@@H](O)[C@H](O6)CO)O)NC(=O)C

subset

  • 3_STAR

synonym EXACT

  • (2S,3R,4E)-2-alkanamido-3-hydroxyoctadec-4-en-1-yl 2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)]-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside

synonym RELATED

  • (2S,3R,4E)-2-alkanamido-3-hydroxyoctadec-4-en-1-yl N-acetyl-beta-D-galactosaminyl-(1->4)-[5-acetyl-alpha-neuraminyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucoside
  • beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->3)]-beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
  • (Gal)2 (GalNAc)2 (Glc)1 (Neu5Ac)1 (Cer)1
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta1-1Cer
  • GalNAc-GM1b
  • GalNAc-isoGM1
  • IV(4)GalNAcGM1b
  • N-acetylgalactosaminyl GM1b

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:61753

Download this concept:

RDF/XML TURTLE JSON-LD